Parkinson's disease can cause dementia, but it does not always
Some people with Parkinson's develop cognitive decline over time, while others do not. When dementia does occur alongside Parkinson's, it is called Parkinson's disease dementia (PDD). The risk increases the longer someone has had Parkinson's — roughly 24 to 31 percent of people with Parkinson's will develop dementia within 8 to 10 years of their diagnosis, though this varies widely based on age at onset, disease progression, and individual factors.
The dementia associated with Parkinson's is different from Alzheimer's disease. It typically involves problems with attention, planning, and processing speed rather than memory loss alone. A person might struggle to follow conversations, organize tasks, or think through multi-step problems, while remembering events from their life relatively well — at least in the early stages.
Not everyone with Parkinson's will face this complication. Some people live with motor symptoms (tremor, stiffness, slowness) for decades without significant cognitive changes. The unpredictability is one reason it matters to understand the difference between normal aging, Parkinson's-related cognitive changes, and dementia itself.
Key Takeaways
- Parkinson's disease dementia occurs in some but not all people with Parkinson's, and risk increases with disease duration and age at diagnosis.
- Parkinson's dementia typically affects planning, attention, and processing speed before memory, which distinguishes it from Alzheimer's disease.
- Early signs include difficulty with complex tasks, slower thinking, and trouble organizing thoughts, which can be subtle and straightforward to miss.
- Medications used to treat Parkinson's motor symptoms can sometimes worsen cognitive problems, so dosing adjustments may be necessary.
- A neurologist can assess cognitive changes through testing and imaging to determine whether decline is normal aging, Parkinson's-related, or dementia.
How Parkinson's affects the brain and thinking
Parkinson's disease damages nerve cells that produce dopamine, a chemical that controls movement. But Parkinson's also affects other brain regions and neurotransmitters — including those involved in attention, memory, and executive function (planning and decision-making). Over time, the disease can spread to affect these cognitive systems.
The brain changes in Parkinson's dementia involve not just dopamine loss but also the buildup of a protein called alpha-synuclein. This same protein appears in Alzheimer's disease and Lewy body dementia, which is why the cognitive symptoms can overlap across these conditions. A person might have Parkinson's pathology, Alzheimer's pathology, or both — which complicates prediction and treatment.
Age at diagnosis matters significantly. Someone diagnosed with Parkinson's at 40 has a different risk profile than someone diagnosed at 75. Younger-onset Parkinson's tends to progress more slowly, while older-onset Parkinson's carries higher dementia risk. This is one reason why two people with the same diagnosis can have very different long-term outcomes.
Early signs of cognitive change in Parkinson's
Cognitive decline in Parkinson's often starts subtly. A person might notice they are slower to process information — taking longer to understand what someone said, or needing more time to make decisions. They may struggle with multitasking or organizing a sequence of steps, such as planning a meal or managing finances. These changes can be mistaken for normal aging or attributed to depression, which also occurs in Parkinson's.
Other early signs include difficulty concentrating, trouble finding words (though not as severe as in some dementias), and changes in mood or motivation. Some people experience visual hallucinations — seeing things that are not there — which can be an early cognitive symptom in Parkinson's. A person might see a person or animal in the room that no one else sees, and be aware it is not real.
The key distinction is that these changes develop over months or years, not overnight. A sudden shift in thinking or memory — confusion that appears within days or weeks — suggests something else, such as infection, medication side effect, or stroke, and warrants when ready medical attention.
The role of Parkinson's medications in cognitive symptoms
Ironically, some medications that treat Parkinson's motor symptoms can worsen thinking and memory. Anticholinergic drugs — older medications that reduce tremor and rigidity — are known to impair cognition, especially in older adults. If someone starts a Parkinson's medication and their thinking becomes noticeably worse, this is not necessarily a sign of disease progression; it may be a medication effect.
A neurologist can adjust dosing, switch to a different medication, or remove anticholinergic drugs to see whether cognition improves. This is one reason why regular follow-up appointments matter — cognitive changes need to be evaluated in the context of what medications are being taken and when they were started or changed.
Dopamine agonists (medications that mimic dopamine) can also cause confusion or hallucinations in some people, particularly at higher doses or in older adults. The goal is to find a balance between controlling motor symptoms and preserving thinking as much as possible.
How doctors assess cognitive decline
A neurologist does not diagnose dementia based on a single conversation. Instead, they use cognitive screening tests — brief, standardized assessments that measure memory, attention, language, and executive function. Common tests include the Montreal Cognitive Assessment (MoCA) and the Mini-Cog. These take 10 to 20 minutes and can be repeated over time to track changes.
If screening suggests cognitive decline, the doctor may order brain imaging (MRI or CT scan) to rule out stroke, tumor, or other structural problems. They may also ask detailed questions about when changes started, how they have progressed, and how they affect daily life. Family members often provide important information, since people with early cognitive decline may not notice or report their own changes accurately.
A diagnosis of Parkinson's disease dementia typically requires cognitive decline that interferes with daily activities and is not explained by depression, medication, or another condition. The diagnosis is clinical — based on history, examination, and testing — not on a single blood test or scan.
Parkinson's dementia versus other types of dementia
Parkinson's disease dementia, Lewy body dementia, and Alzheimer's disease can look similar but have important differences. Lewy body dementia causes cognitive symptoms first (hallucinations, confusion, memory loss), followed by movement problems. Parkinson's disease dementia starts with movement symptoms and cognitive decline comes later. Alzheimer's disease typically begins with memory loss and progresses to affect other thinking skills.
The distinction matters because treatment approaches differ. Medications that help one type of dementia may worsen another. For example, certain antipsychotic drugs can be dangerous in Lewy body dementia but may be necessary in other conditions. A neurologist's diagnosis helps guide which treatments are safe and which to avoid.
In practice, the boundaries blur. Some people have pathology from more than one condition — Parkinson's changes plus Alzheimer's changes, for instance. Brain autopsy is the only way to know for certain, which is why some people choose to donate their brains to research. During life, the diagnosis is based on the pattern of symptoms and how they developed over time.
What you can do if cognitive changes occur
If you or a family member with Parkinson's notices thinking or memory changes, the first step is to mention them at the next neurology appointment. Bring a list of specific examples — when the changes started, what tasks have become harder, whether they are getting worse. This information helps the doctor determine whether the changes are normal aging, medication-related, or signs of dementia.
Cognitive changes do not automatically mean dementia is developing. Some people have mild cognitive impairment — noticeable decline that does not yet interfere significantly with daily life — and remain stable for years. Others progress more quickly. Regular monitoring through cognitive testing allows the doctor to track the pace of change and adjust treatment accordingly.
Lifestyle factors may help preserve thinking skills. Physical exercise, cognitive stimulation (puzzles, reading, learning), social engagement, and sleep quality all support brain health in Parkinson's. While these cannot prevent dementia, they may slow cognitive decline or help maintain function longer. A neurologist or neuropsychologist can recommend specific strategies tailored to the person's situation.
Frequently Asked Questions
If I have Parkinson's, will I definitely get dementia?
No. Many people with Parkinson's never develop dementia. Risk increases with longer disease duration and older age at diagnosis, but individual outcomes vary widely. Some people have Parkinson's for 20 or 30 years with minimal cognitive change.
Can Parkinson's dementia be reversed?
Dementia caused by Parkinson's disease itself cannot be reversed, but cognitive decline caused by medication, depression, sleep problems, or other treatable conditions can sometimes improve. A neurologist can identify which factors are reversible and address them.
How fast does Parkinson's dementia progress?
Progression varies. Some people have slow, gradual decline over many years. Others decline more quickly. There is no way to predict an individual's course, which is why regular monitoring and follow-up appointments are important.
What medications treat Parkinson's dementia?
Cholinesterase inhibitors (such as donepezil) are sometimes used, as they may help with attention and processing speed. Levodopa, the main Parkinson's medication, may also help cognition in some people. Treatment is individualized based on symptoms and what has worked in the past.
Should I tell my doctor about small memory lapses?
Yes. Small changes can be normal aging, but they can also be early signs of cognitive decline. Your doctor needs to know the full picture to distinguish between normal variation and a pattern that requires monitoring or treatment adjustment.